🔗 Permalink

Assignee profile:

Cellestis Limited

City:

Chadstone

Country:

Australia

Published Applications:

Last publication date:

2022-04-28

Patent Grants:

Last grant date:

2024-12-31

Top Inventors for applications by Cellestis Limited

These are the the leading inventors for applications assigned to Cellestis Limited:

Massimo Amicosante 6 Rome, Italy
Francesca Mariani 6 Rome, Italy
Vittorio Colizzi 6 Rome, Italy
Cesare Saltini 6 Grottaferrata, Italy

Jeff Boyle 5 Pearcedale, Australia
Emily Manktelow 2 Diamond Creek, Australia
Rachel De Las Heras 1 Belgrave, Australia
Carmen Munian 1 Chadstone, Australia

Ashley Knights 1 Chadstone, Australia

Recent patent applications by Cellestis Limited

Cellestis Limited based in Chadstone, AU has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-04-28 ✅ Patent 12,181,476 granted on 2024-12-31

US20220128558A1

Physics

Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom

#2 | 2020-12-10 ✅ Patent 11,275,086 granted on 2022-03-15

US20200386755A1

Physics

Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom

#3 | 2020-08-27 ✅ Patent 11,841,367 granted on 2023-12-12

US20200271648A1

Physics

TLR agonist-enhanced in vitro assay of cell mediated immune responsiveness

#4 | 2020-05-07 ✅ Patent 12,153,042 granted on 2024-11-26

US20200141927A1

Physics

Cell mediated immune response assay

#5 | 2019-12-19 ✅ Patent 10,788,491 granted on 2020-09-29

US20190383812A1

Physics

Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom

#6 | 2018-08-09 ✅ Patent 10,408,833 granted on 2019-09-10

US20180224450A1

Physics

Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom

#7 | 2015-10-29 ✅ Patent 9,829,490 granted on 2017-11-28

US20150309023A1

Physics

Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom

#8 | 2014-08-07 ✅ Patent 9,983,207 granted on 2018-05-29

US20140220601A1

Physics

Cell mediated immune response assay with enhanced sensitivity

#9 | 2014-06-05 ✅ Patent 10,551,380 granted on 2020-02-04

US20140154712A1

Physics

TLR agonist-enhanced in vitro assay of cell mediated immune responsiveness

#10 | 2013-09-26 ✅ Patent 9,110,061 granted on 2015-08-18

US20130252260A1

Physics

Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom

#11 | 2013-02-07 ✅ Patent 9,459,253 granted on 2016-10-04

US20130034844A1

Physics

Assay for measuring cell-mediated immunoresponsiveness

Also check out Cellestis Limited's (Chadstone, Australia) applicant profile with 8 patent applications submitted.

AssigneeID:

8276 ⎘